From: Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States
Influenza scenario
IPD
Hospitalized pneumonia
Non-Hospitalized pneumonia
Vaccination
Total
Normal season
$ 235 M
$ 509 M
$ 96 M
($ 367 M)
$ 472 M
Pandemic similar to 2009–2010 H1N1
$ 358 M
$ 812 M
$ 213 M
$ 1.02 B